Is Clinical Trial Complexity Is Quietly Eroding Early-Phase Integrity?
Photo: Marta BrancoWe are living through an era of astonishing biological breakthroughs. Glp-1 combinations, targeted antibody-drug conjugates, and individualized gene-editing therapies dominate industry headlines weekly. On paper, biopharma pipelines have never looked more sophisticated.Yet on…